Lautenbach et al identified risk factors associated with fluoroquinolone resistance in nosocomial infections with Escherichia coli and Klebsiella pneumoniae. These can help identify a patient who should be monitored more closely for failure to respond to therapy. The authors are from the University of Pennsylvania in Philadelphia.
